Webinar

Diagnosing the health (policy) of our nation: The impact of November’s elections

Join us for an insightful webinar with reimbursement policy expert Corey Ford that will explore the critical impact of the upcoming November general election on federal health policy heading into 2025 and beyond. As the landscape shifts, understanding the implications of election outcomes on health policy becomes essential for stakeholders across the healthcare spectrum.
headshot
headshot
Session: Diagnosing the Health (Policy) of our Nation: The impact of November’s elections
Recorded Date: Thursday October 31, 2024 
Speaker: Corey Ford, VP Reimbursement and Policy Insights, Global Pharma Services, Cencora

Corey will provide a comprehensive overview of the current race for the White House and US Congress. We will assess potential scenarios based on various election results and evaluate how these outcomes could influence significant federal laws and programs, including the Inflation Reduction Act (IRA) and Affordable Care Act (ACA). 

Don’t miss this engaging discussion! Corey will share his insights on the possible election outcomes, bolstering your ability to navigate the policy and reimbursement complexities of these impending changes.

Fill out the form below to watch the webinar gain valuable knowledge on how to prepare for the evolving health policy landscape!
headshot
Key learnings:

  • Potential impact of the results of the November elections on health policy 
  • Potential scenarios: Explore various outcomes of the presidential and congressional races and their implications for healthcare
  • Key program analysis: Gain insights into the future of major federal programs like the IRA and ACA 
  • Strategic guidance: Learn how to prepare for and navigate potential changes to health policy post-election
  • Expert perspectives: Hear expert analysis and forecasts on the evolving landscape and its influence on healthcare

Who should attend?
Directors and executives at biopharmaceutical companies responsible for health policy, market access, and patient access, based in the U.S and looking at commercialization. Departments: Market Access, Patient Access/ Support, Commercialization, Strategy, Pricing, Reimbursement, Health Economics and Outcomes Research
Washington DC Capital
Pardot Form

Related resources

Article

Why a strong transitional service agreement is vital for product life cycle management

Article

Q&A for innovators: Navigating the complex regulatory world of ATMPs/CGTs

Article

The drivers and benefits of the UK’s clinical trials regulation amendment

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.